GlassScriptPhysician profile
Robert H Pittman
NPI 1043254535
$24,695.37
in general payments reported to CMS, 2019-2025
43 companies · $1,712 in 2025
The $1,712 reported for 2025 was more than what 75% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,720 · 2020: $241 · 2021: $350 · 2022: $971 · 2023: $4,389 · 2024: $12K · 2025: $1,712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,325 · Food and Beverage: $6,114 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,025 · Travel and Lodging: $710 · Long Term Medical Supply Or Device Loan: $194 · Education: $45.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,325.00 |
| Food and Beverage | $6,114.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,025.00 |
| Travel and Lodging | $709.78 |
| Long Term Medical Supply Or Device Loan | $193.55 |
| Education | $45.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $9,508.80 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $7,436.68 | 2021-2024 | |
| Celgene Corporation | $2,431.91 | 2021-2024 | Zeposia |
| Janssen Biotech, INC. | $1,125.52 | 2019-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $668.79 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $526.49 | 2019-2025 | Entyvio, Eohilia |
| Lilly USA, LLC | $323.24 | 2023-2025 | Omvoh, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $264.91 | 2019-2023 | Xifaxan, Plenvu, Trulance |
| Qol Medical, LLC | $233.10 | 2019-2025 | Sucraid, Sucraid |
| Ardelyx, INC. | $205.37 | 2022-2025 | Ibsrela |
| Genzyme Corporation | $201.17 | 2022-2025 | |
| Pentax of America, INC. | $193.55 | 2024 | Video Colonoscope |
| Corcept Therapeutics | $168.60 | 2024-2025 | Korlym |
| Medtronic, INC. | $144.52 | 2023-2024 | Minimed 780g, Appose Ulc |
| Janssen Scientific Affairs, LLC | $132.44 | 2019-2020 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $112.90 | 2019-2025 | Rebyota |
| Merck Sharp & Dohme LLC | $101.28 | 2021-2024 | Dificid |
| Celltrion USA INC. | $83.43 | 2024-2025 | Zymfentra, Vegzelma |
| Madrigal Pharmaceuticals | $71.81 | 2025 | Rezdiffra |
| Novo Nordisk INC | $66.13 | 2019-2025 | Wegovy |
| Xeris Pharmaceuticals, INC. | $66.09 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Regeneron Healthcare Solutions, INC. | $63.22 | 2023-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $56.03 | 2025 | Voquezna |
| Asensus Surgical, INC. | $55.86 | 2023 | Senhance |
| Ironwood Pharmaceuticals, INC | $53.86 | 2019-2022 | |
| Daiichi Sankyo INC. | $48.62 | 2025 | Injectafer |
| Amgen INC. | $48.05 | 2019-2025 | Evenity |
| Amarin Pharma, INC. | $29.24 | 2019 | |
| Sanofi Pasteur INC. | $28.68 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.12 | 2023-2024 | Cyltezo |
| Ibsa Pharma INC. | $23.59 | 2025 | Licart, Tirosint, Flector |
| Intercept Pharmaceuticals, INC. | $22.57 | 2020 | |
| Biocon Biologics INC | $20.13 | 2025 | Yesintek |
| Blueprint Medicines Corporation | $19.51 | 2024 | Ayvakit |
| Sandoz INC. | $18.51 | 2024 | Hyrimoz |
| Fresenius Kabi USA, LLC | $15.00 | 2023 | |
| Braintree Laboratories, INC. | $14.98 | 2019 | |
| Shire North American Group INC | $14.93 | 2019 | |
| Ucb, INC. | $14.85 | 2020 | |
| Redhill Biopharma INC. | $13.88 | 2023 | Aemcolo, Talicia, Movantik |
| Dova Pharmaceuticals | $13.65 | 2019 | |
| Glaxosmithkline, LLC. | $12.93 | 2022 | |
| Allergan, INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pittman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.